<DOC>
	<DOC>NCT02408523</DOC>
	<brief_summary>Evaluating efficacy &amp; safety of lacosamide versus Placebo in a blinded fashion as add-on Therapy for Primary Generalized Tonic-clonic (PGTC) seizures in subject 4 years of age with idiopathic generalized epilepsy currently taking 1 to 3 antiepileptic drugs. Maximum duration of study drug administration is 28 weeks. Eligible subjects may choose to enter the open-label extension study after completion.</brief_summary>
	<brief_title>A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy, Generalized</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Lacosamide</mesh_term>
	<criteria>Subject with a confirmed diagnosis at least 24 weeks prior to Visit 1 and a disease onset prior to 30 years of age, consistent with idiopathic generalized epilepsy (IGE) experiencing primary generalizedtonicclonic (PGTC) seizures (Type IIE) that are classifiable according to the International League Against Epilepsy (ILAE) Classification of Epileptic Seizures (ILAE, 1981) Subject has 3 PGTC seizures during the 16week Combined Baseline (12week Historical Baseline plus 4week Prospective Baseline) If a brain magnetic resonance imaging (MRI)/computed tomography (CT) scan has been performed, there must be no evidence of any progressive abnormality or any lesion likely to be associated with partialonset seizures Subject has been maintained on a stable dose regimen of 1 to 2 nonbenzodiazepine marketed Antiepileptic drugs (AEDs) OR 1 to 3 AEDs (with 1 AED identified as a benzodiazepine) for at least 28 days prior to Visit 1 with or without additional concurrent stable Vagus nerve stimulation (VNS) Subjects are required to have had an electroencephalogram (EEG) report consistent with IGE (eg, generalized 3Hz epileptiform discharges and a normal EEG background) confirmed by a Central Reviewer History of partial onset seizures or EEG findings indicating partial onset seizures Symptomatic generalized epilepsy, e.g. LennoxGastaut Syndrome Lifetime history of suicide attempt, or suicidal ideation in past 6 months Women of child bearing potential must practice contraception according to protocol requirements Regular use of clozapine, monoamine oxidase (MAOA) inhibitors, barbiturates (for indication other than epilepsy) within 28 days prior to Visit 1 Use of Vigabatrin within the last 6 months</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Lacosamide</keyword>
	<keyword>Vimpat</keyword>
	<keyword>Epilepsy</keyword>
	<keyword>Children</keyword>
	<keyword>Primary Generalized Tonic Clonic seizures</keyword>
	<keyword>Idiopathic Generalized Epilepsy</keyword>
	<keyword>Adults</keyword>
</DOC>